#8,695 by institutional money · Stock
Ensysce Biosciences, Inc. (ENSC)
Institutional ownership from Q3 2026 Form 13F filings
$0.36
−2.51% today
Market closed. Prices as of Nov 20, 8:11 AM ET
- 13F holders
- 19 (+4)
- Held by 13F filers, live
- $3.9M
- Shares held
- 10,695,404
- Share of stock outstanding
- 55.0%
- Net buying in Q3 2026
- +$3.5M
- New positions / sold out
- 7 / 4
Largest holders
19 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Adage Capital Partners GP, L.l.c. | 9,471,711 | $3.4M | <0.1% | Added +6,227% |
| Jane Street Group, LLC | 466,084 | $168K | <0.1% | Added +123% |
| Citadel Advisors LLC Ken Griffin | 243,089 | $88K | <0.1% | Added +182% |
| StoneX Group Inc. | 138,563 | $50K | <0.1% | New |
| Vanguard Fiduciary Trust Co | 110,799 | $40K | <0.1% | New |
| Perceptive Advisors LLC | 86,666 | $31K | <0.1% | Unchanged |
| Geode Capital Management, LLC | 61,862 | $22K | <0.1% | Reduced −1% |
| Virtu Financial LLC | 41,230 | $15K | <0.1% | Reduced −57% |
| Renaissance Technologies LLC | 30,160 | $11K | <0.1% | New |
| XTX Topco Ltd | 19,110 | $7K | <0.1% | Reduced −75% |
| Vanguard Capital Management LLC | 12,854 | $5K | <0.1% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,081 | $2K | <0.1% | Reduced −0% |
| FNY Investment Advisers, LLC | 3,000 | $1K | <0.1% | New |
| Robinhood Markets, Inc. | 2,949 | $1K | <0.1% | First filing |
| SBI Securities Co., Ltd. | 627 | $226 | <0.1% | Reduced −2% |
| Citigroup Inc | 456 | $164 | <0.1% | New |
| Ascentis Independent Advisors | 80 | $29 | <0.1% | New |
| BlackRock, Inc. | 65 | $23 | <0.1% | Unchanged |
| UBS Group AG | 18 | $6 | <0.1% | New |